GlaxoSmithKline: all 4,196 studies
Page 16 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in AdultsCompletedNCT00968539Phase 3Results posted
- Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in AdultsCompletedNCT00968526Phase 3Results posted
- Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne MedicationsCompletedNCT00964366Phase 4Results posted
- A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial AcneCompletedNCT00964223Phase 4Results posted
- Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)CompletedNCT00964158Phase 3Results posted
- Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib)CompletedNCT00964028Phase 3Results posted
- Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and AdolescentsCompletedNCT00963937Phase 3Results posted
- Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612CompletedNCT00955682Phase 3Results posted
- Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in AdultsCompletedNCT00951041Phase 2Results posted
- A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive SubjectsCompletedNCT00951015Phase 2Results posted
- A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to RaltegravirCompletedNCT00950859Phase 2Results posted
- Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed ChildrenCompletedNCT00950833Phase 3Results posted
- GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary DiseaseCompletedNCT00950807Phase 2Results posted
- Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive HistologyCompletedNCT00950755Phase 2Results posted
- Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative AdolescentsCompletedNCT00950612Phase 2Results posted
- Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female SubjectsCompletedNCT00947115Phase 3Results posted
- Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.CompletedNCT00945282Phase 2Results posted
- A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced MelanomaCompletedNCT00942162Phase 2Results posted
- Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the ElderlyCompletedNCT00938392Phase 3Results posted
- Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian InfantsCompletedNCT00938327Results posted
- Retreatment of Patients With Non-Hodgkin's Lymphoma Who Have Previously Responded to Iodine-131 Anti B1 AntibodyCompletedNCT00938041Phase 2Results posted
- Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study SubjectsCompletedNCT00937950Phase 3Results posted
- Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix) in InfantsCompletedNCT00937404Phase 1Results posted
- Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human SubjectsCompletedNCT00937326Phase 2Results posted
- Study of Safety and Efficacy of a Sequential Regimen Consisting of Three Cycles of Fludarabine Followed by Tositumomab and Iodine I 131 TositumomabCompletedNCT00933335Phase 2Results posted
- Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 StudyCompletedNCT00929526Phase 3Results posted
- Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 YearsCompletedNCT00929331Phase 3Results posted
- Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne MedicationsCompletedNCT00926367Phase 4Results posted
- A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple MyelomaTerminatedNCT00920556Phase 2Results posted
- Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in ToddlersCompletedNCT00920439Phase 3Results posted
- Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)CompletedNCT00920426Phase 2Results posted
- A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in AdultsCompletedNCT00920374Phase 3Results posted
- Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173ACompletedNCT00920218Phase 2Results posted
- Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory LeukemiasCompletedNCT00920140Phase 2Results posted
- Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart RhythmCompletedNCT00911300Phase 2Results posted
- The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese PatientsCompletedNCT00911157Phase 3Results posted
- Booster Vaccination Study With a Pneumococcal Vaccine in Children Primed With the Same VaccineCompletedNCT00911144Phase 3Results posted
- A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment ElevationCompletedNCT00910962Phase 2Results posted
- Post Market Surveillance for Infanrix™CompletedNCT00908115Results posted
- Efficacy and Safety Study of Eltrombopag in Pediatric Patients With Thrombocytopenia From Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00908037Phase 2Results posted
- Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™CompletedNCT00907777Phase 3Results posted
- Study to Test GSK256073 in Patients With DyslipidemiaCompletedNCT00903617Phase 2Results posted
- Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Lovaza® and Simvastatin Therapy in Hypertriglyceridemic SubjectsCompletedNCT00903409Phase 3Results posted
- 28 Day Repeat Dose in Cystic Fibrosis PatientsCompletedNCT00903201Phase 2Results posted
- Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous MelanomaCompletedNCT00896480Phase 2Results posted
- Safety and Efficacy Study in Patients With Major Depressive DisorderCompletedNCT00896363Phase 2Results posted
- Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young AdultsCompletedNCT00896064Phase 2Results posted
- Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working SeedsCompletedNCT00892775Phase 2Results posted
- A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO WashCompletedNCT00891982Phase 3Results posted
- A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™CompletedNCT00891293Phase 4Results posted
- Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib VaccinesCompletedNCT00891176Phase 3Results posted
- A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of AcneCompletedNCT00887484Phase 4Results posted
- A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive DisorderTerminatedNCT00880399Phase 2Results posted
- A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive DisorderTerminatedNCT00880048Phase 2Results posted
- Thiazolidinedione Intervention With Vitamin D EvaluationTerminatedNCT00879970Phase 4Results posted
- Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.CompletedNCT00877877Phase 3Results posted
- Nutrition, Physical Performance & Fitness in Indian School ChildrenCompletedNCT00876018Phase 4Results posted
- Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United StatesCompletedNCT00875641Results posted
- Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™CompletedNCT00875485Phase 4Results posted
- Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.TerminatedNCT00871741Phase 2Results posted
- Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung CancerCompletedNCT00871403Phase 2Results posted
- Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in InfantsCompletedNCT00871338Phase 2Results posted
- Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 YearsCompletedNCT00871117Phase 3Results posted
- Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.CompletedNCT00871000Phase 3Results posted
- Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in AfricaCompletedNCT00866619Phase 3Results posted
- Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)CompletedNCT00866294Phase 3Results posted
- Safety And Efficacy Of Maraviroc In Patients For HIV Patients (Regulatory Post Marketing Commitment Plan)CompletedNCT00864474Results posted
- Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of AgeCompletedNCT00861744Phase 2Results posted
- Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver DiseaseCompletedNCT00861601Phase 2Results posted
- Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive DiseaseCompletedNCT00861380Phase 3Results posted
- A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild AsthmaticsCompletedNCT00857857Phase 2Results posted
- A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00857766Phase 4Results posted
- Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving MaravirocCompletedNCT00853840Phase 4Results posted
- A Study to Evaluate the Efficacy and Tolerability of Topical Therapies for the Condition of Plaque-Type PsoriasisCompletedNCT00852761Phase 4Results posted
- Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSACompletedNCT00852540Phase 3Results posted
- GSK2190915 Moderate to Severe Asthma StudyTerminatedNCT00850642Phase 2Results posted
- Non-Interventional Study Of Celsentri® In Treatment Experienced Patients With CCR5-Tropic HIV-InfectionCompletedNCT00850395Results posted
- A Study of Safety and Clinical Activity of Immunotherapy Plus Chemotherapy in Metastatic Melanoma PatientsTerminatedNCT00849875Phase 2Results posted
- Treatment With Pazopanib for Neoadjuvant Breast CancerCompletedNCT00849472Phase 2Results posted
- Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or ThailandCompletedNCT00849381Phase 3Results posted
- Safety and Efficacy of Albiglutide in Type 2 DiabetesCompletedNCT00849056Phase 3Results posted
- Safety and Efficacy Study of Albiglutide in Type 2 DiabetesCompletedNCT00849017Phase 3Results posted
- A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge ChamberCompletedNCT00848965Phase 4Results posted
- A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing SurgeryCompletedNCT00843492Phase 3Results posted
- Efficacy and Safety Study of GSK679586 in Patients With Severe AsthmaCompletedNCT00843193Phase 2Results posted
- Migraine Study in Adolescent PatientsCompletedNCT00843024Phase 3Results posted
- Evaluation of the Efficacy and Tolerability of Clobetasol Propionate Foam Compared to Vehicle FoamCompletedNCT00842153Phase 4Results posted
- Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial AcneCompletedNCT00841776Phase 4Results posted
- A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 DiabetesCompletedNCT00839527Phase 3Results posted
- Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850ACompletedNCT00839254Phase 3Results posted
- A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 DiabetesCompletedNCT00838916Phase 3Results posted
- Efficacy and Safety of Albiglutide in Treatment of Type 2 DiabetesCompletedNCT00838903Phase 3Results posted
- Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate AcneCompletedNCT00837213Phase 4Results posted
- Evaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.CompletedNCT00835237Phase 3Results posted
- Safety Escalating Repeat IV, in Stroke PatientsCompletedNCT00833989Phase 2Results posted
- Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.CompletedNCT00829010Phase 3Results posted
- Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)CompletedNCT00828750Phase 3Results posted
- Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand DermatitisCompletedNCT00828464Phase 4Results posted
- A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected PatientsCompletedNCT00827112Phase 2Results posted
- Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's DiseaseCompletedNCT00823836Phase 3Results posted